| Quantity | 1 | 1 | 100 μg | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | MERS-CoV virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. MERS-CoV stock can be MERS-CoV virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. MERS-CoV stock can be used in the development of MERS-CoV diagnostics and in vaccine development and R&D.... Read More | Recombinant Ebola Virus-like Particles (EBOV VLPs) are produced in mammalian HEK293 human cells, assembled with Nucleoprotein, Glycoprotein and Matrix protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material Recombinant Ebola Virus-like Particles (EBOV VLPs) are produced in mammalian HEK293 human cells, assembled with Nucleoprotein, Glycoprotein and Matrix protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. EBOV VLPs can be used in the development of EBOV diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More | This product GTTS-WK5188MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the MAGE-A4 protein. This product can be used in -related researches. | The product SIRGT00060WQ is a type of small interfering RNA (siRNA) that targets ADA gene and regulates the expression of gene. The siRNA interferes with the expression of ADA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potentialThe product SIRGT00060WQ is a type of small interfering RNA (siRNA) that targets ADA gene and regulates the expression of gene. The siRNA interferes with the expression of ADA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | The product SIRGT02109WQ-2F is a type of small interfering RNA (siRNA) that targets AP2A1 gene and regulates the expression of gene. The siRNA interferes with the expression of AP2A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNAThe product SIRGT02109WQ-2F is a type of small interfering RNA (siRNA) that targets AP2A1 gene and regulates the expression of gene. The siRNA interferes with the expression of AP2A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-deoxy-2_-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |